Rockefeller Capital Management L.P. Innoviva, Inc. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$11.61 - $15.22 $1,161 - $1,522	-100 Reduced 80.0%	25 $0
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $1,016 - $1,411	71 Added 131.48%	125 $1,000
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $584 - $769	38 Added 237.5%	54 $1,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $3,738 - $4,399	-235 Reduced 93.63%	16 $0
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $3,278 - $4,327	251 New	251 $4,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.